Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1496201 TEL AVIV, L3

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,385,050
+$6,509,496 QoQ
Shares Held
127,000
+386.6% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Sep 30, 2023
CallValue
$0
CallShares
0
PutValue
$2,814,784
PutShares
82,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $300,609,660 across 61 Biotechnology names. XENE ranks #8 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 XENE
Xenon Pharmaceuticals Inc.
This page
127,000 $7,385,050

All Filings in XENE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,385,050 127,000
2025-03-31 $875,554 26,097
2024-12-31 $2,042,202 52,097
2023-09-30 $2,814,784 82,400
2023-09-30 $1,330,839 38,959
2021-09-30 $5,707,232 373,510
2021-06-30 $5,141,540 276,130